Investment Portfolio - As of December 31, 2024, the company’s investment portfolio included interests in 697 properties, comprising 524 outpatient medical properties, 139 lab properties, 15 CCRCs, and 19 other non-reportable properties[26]. - Approximately 78% of outpatient medical buildings are located on or adjacent to hospital campuses, with 96% affiliated with hospital systems as of December 31, 2024[36]. - The lab properties are primarily located in key markets such as San Francisco (53%), San Diego (17%), and Boston (28%), with 88% of lab properties being triple-net leased[40]. - The outpatient medical segment includes nine hospitals, all of which are triple-net leased, providing services paid for by private sources and government programs[38]. - A significant portion of the company's lab portfolio, approximately 67% based on gross asset value as of December 31, 2024, is concentrated in California, which is prone to natural disasters[110]. Financial Performance - The Adjusted NOI for the outpatient medical segment was $748,730, for the lab segment was $590,606, and for the CCRC segment was $136,104 for the year ended December 31, 2024[27]. - The company reported a net income applicable to common shares of $242.4 million, a decrease of 20.3% from $304.3 million in 2023[336]. - The company's Nareit FFO applicable to common shares for the year ended December 31, 2024, was $1.09 billion, an increase of 10.9% from $985.2 million in 2023[336]. - The company reported an AFFO applicable to common shares of $1.14 billion for the year ended December 31, 2024, compared to $884.2 million in 2023, reflecting a year-over-year increase of 29.1%[336]. - The company incurred transaction and merger-related costs of $115.1 million in 2024, significantly higher than $13.8 million in 2023[336]. Debt and Financing - The company maintains a strong investment-grade balance sheet with ample liquidity and long-term fixed-rate debt financing, reducing exposure to interest rate volatility[30]. - As of December 31, 2024, approximately 97% of consolidated debt was fixed rate debt, with a weighted average effective interest rate of 4.04%[321]. - The company's outstanding indebtedness as of December 31, 2024, was approximately $8.7 billion, which may increase and adversely affect future operations[157]. - Increased borrowing costs due to rising interest rates could materially impact the company's ability to refinance existing debt and conduct investment activities[150]. - Compliance with covenants in debt instruments limits operational flexibility, and breaches could lead to adverse actions by creditors[158]. Growth Strategy - The company expects to achieve external growth through acquisitions, development, and redevelopment, leveraging its competitive position in the healthcare real estate market[32]. - The company’s strategy includes building long-term leasing relationships and extending lease terms to reduce downtime and secure high-quality tenants[30]. Regulatory and Compliance Risks - The healthcare industry is expected to face increased regulation and pressure in areas such as fraud, waste, and abuse, which may complicate compliance efforts for operators and tenants[52]. - Effective January 16, 2024, Medicare and Medicaid nursing facilities must disclose new data about ownership and management, which could complicate compliance and affect participation in these programs[59]. - Tenants and operators participating in governmental healthcare programs are subject to audits and investigations, which may lead to reduced reimbursement rates due to ongoing healthcare reform initiatives[58]. - Compliance with federal and state privacy laws, including HIPAA, is critical, and failure to protect health information could result in civil or criminal liability[56]. - The introduction of new healthcare regulations may impact the ability of tenants to expand or change their businesses, particularly in states with certificate of need laws[60]. Environmental and Sustainability Initiatives - Environmental management programs are in place to enhance sustainability and reduce the carbon footprint, which aligns with corporate responsibility goals[69]. - The company has been recognized for sustainability performance, including being named an ENERGY STAR Partner of the Year for Sustained Excellence in 2024[12]. - Reported a reduction of 2.1% in Scope 1 and Scope 2 greenhouse gas emissions in 2023 compared to 2022[12]. - Achieved 6 new LEED certifications and 19 new ENERGY STAR certifications in 2024[12]. - The company has established corporate goals to reduce greenhouse gas emissions, energy, water, and waste, with potential reputational risks if these goals are not met[135]. Operational Risks - The company faces competition from various institutional investors and REITs, which may impact its ability to capitalize on investment opportunities[50]. - Rising labor costs and personnel shortages may adversely impact the company and its tenants[79]. - The reliance on technology increases risks related to unauthorized access and cyber threats, necessitating continuous monitoring and upgrades to IT systems[57]. - Cybersecurity incidents pose significant risks, with potential disruptions to operations and unauthorized access to confidential information, which could harm the company's reputation and financial condition[141]. - The company may incur significant costs to comply with corporate impact policies or third-party expectations, which could negatively affect financial results[135]. Legal and Litigation Risks - The company faces various class-action lawsuits, which could lead to significant defense costs and materially decrease anticipated revenues[112]. - Unfavorable resolutions of litigation could lead to significant costs and disruptions, adversely affecting business operations[129]. - The company may incur substantial costs related to litigation, insurance, and compliance, which could negatively impact financial results[127]. Market and Economic Conditions - Economic conditions and natural disasters in geographic areas where the company has concentrated investments could adversely affect its financial condition[108]. - Market volatility and uncertainty could impair the company's ability to raise capital and fund acquisition and development activities[149]. - Changes to governmental reimbursement programs, such as Medicare and Medicaid, may adversely affect tenants' ability to meet financial obligations[168]. Shareholder and Equity Matters - The company issued 162 million shares of common stock as part of the merger, converting each outstanding share of Physicians Realty Trust into 0.674 shares of its common stock[326]. - The company has established an at-the-market equity offering program with a gross sales price of up to $1.5 billion, which was amended in March 2024[327]. - The company relies on distributions from Healthpeak OP to pay dividends and meet obligations, with stockholder claims being structurally subordinated to all liabilities of Healthpeak OP[196]. - The company has a 9.8% ownership limit on common stock to preserve its qualification as a REIT, which may delay or prevent transactions that could benefit stockholders[187]. - Conflicts of interest may arise between the interests of stockholders and holders of Healthpeak OP common units, potentially impeding beneficial business decisions[190].
Healthpeak Properties(PEAK) - 2024 Q4 - Annual Report